Skip to main content
S 487 111th Congress Senate Health Administrative law and regulatory procedures Cell biology and embryology Department of Health and Human Services Medical ethics Medical research National Institutes of Health (NIH) Research administration and funding

Stem Cell Research Enhancement Act of 2009

Introduced: February 26, 2009 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 26, 2009
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2562-2563)
Feb 26, 2009
Sponsor introductory remarks on measure. (CR S2562)
Feb 26, 2009
Introduced in Senate
 Plain-English summary Congressional Research Service

Stem Cell Research Enhancement Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo. Limits such research to stem cells that meet the following requirements: (1) the stem cells were derived from human embryos donated from in vitro fertilization clinics, were created for the purposes of fertility treatment, and were in excess of the needs of the individuals seeking such treatment; (2) prior to donation, it was determined that the embryos would never be implanted in a woman and would otherwise be discarded; and (3) the individuals seeking fertility treatment donated the embryos with written informed consent and received no financial or other inducements.

Requires the Secretary to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but that are not derived from a human embryo. Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.

What's happening now February 26, 2009

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S2562-2563)

 Committees of jurisdiction 1